| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A mitochondrial drug to treat AML
|
Pinton, Paolo
|
|
|
129 |
19 |
p. 2597-2599
|
artikel
|
| 2 |
An infant with Pearson syndrome: a rare cause of congenital sideroblastic anemia and bone marrow failure
|
Falcon, Corey P.
|
|
|
129 |
19 |
p. 2710
|
artikel
|
| 3 |
Crebbp loss cooperates with Bcl2 overexpression to promote lymphoma in mice
|
García-Ramírez, Idoia
|
|
|
129 |
19 |
p. 2645-2656
|
artikel
|
| 4 |
Cyclin D1–negative blastoid mantle cell lymphoma exhibiting cleaved to bilobated cytomorphology
|
Wang, Huan-You
|
|
|
129 |
19 |
p. 2711
|
artikel
|
| 5 |
Cytoreductive conditioning intensity predicts clonal diversity in ADA-SCID retroviral gene therapy patients
|
Cooper, Aaron R.
|
|
|
129 |
19 |
p. 2624-2635
|
artikel
|
| 6 |
Editorial Board
|
|
|
|
129 |
19 |
p. i
|
artikel
|
| 7 |
FNDC3B is another novel partner fused to RARA in the t(3;17)(q26;q21) variant of acute promyelocytic leukemia
|
Cheng, Chi Keung
|
|
|
129 |
19 |
p. 2705-2709
|
artikel
|
| 8 |
Human neutrophils mediate trogocytosis rather than phagocytosis of CLL B cells opsonized with anti-CD20 antibodies
|
Valgardsdottir, Rut
|
|
|
129 |
19 |
p. 2636-2644
|
artikel
|
| 9 |
Impact of ibrutinib dose adherence on therapeutic efficacy in patients with previously treated CLL/SLL
|
Barr, Paul M.
|
|
|
129 |
19 |
p. 2612-2615
|
artikel
|
| 10 |
Indoxyl sulfate, a uremic trigger for platelets
|
Diaz-Ricart, Maribel
|
|
|
129 |
19 |
p. 2599-2600
|
artikel
|
| 11 |
Indoxyl sulfate induces platelet hyperactivity and contributes to chronic kidney disease–associated thrombosis in mice
|
Yang, Ke
|
|
|
129 |
19 |
p. 2667-2679
|
artikel
|
| 12 |
Leveraging increased cytoplasmic nucleoside kinase activity to target mtDNA and oxidative phosphorylation in AML
|
Liyanage, Sanduni U.
|
|
|
129 |
19 |
p. 2657-2666
|
artikel
|
| 13 |
Mobilization of allogeneic peripheral blood stem cell donors with intravenous plerixafor mobilizes a unique graft
|
Schroeder, Mark A.
|
|
|
129 |
19 |
p. 2680-2692
|
artikel
|
| 14 |
Mobilizing plasmacytoid dendritic cells
|
Waller, Edmund K.
|
|
|
129 |
19 |
p. 2600-2602
|
artikel
|
| 15 |
Neutrophils: positive or negative?
|
Taylor, Ronald P.
|
|
|
129 |
19 |
p. 2596-2597
|
artikel
|
| 16 |
Rituximab exposure is influenced by baseline metabolic tumor volume and predicts outcome of DLBCL patients: a Lymphoma Study Association report
|
Tout, Mira
|
|
|
129 |
19 |
p. 2616-2623
|
artikel
|
| 17 |
Rituximab immunotherapy: it's getting personal
|
Phelps, Mitch A.
|
|
|
129 |
19 |
p. 2595-2596
|
artikel
|
| 18 |
Validation of single nucleotide polymorphisms in invasive aspergillosis following hematopoietic cell transplantation
|
Fisher, Cynthia E.
|
|
|
129 |
19 |
p. 2693-2701
|
artikel
|
| 19 |
Venetoclax and obinutuzumab in chronic lymphocytic leukemia
|
Fischer, Kirsten
|
|
|
129 |
19 |
p. 2702-2705
|
artikel
|
| 20 |
Vitamin B12 deficiency from the perspective of a practicing hematologist
|
Green, Ralph
|
|
|
129 |
19 |
p. 2603-2611
|
artikel
|
Tijdschrift beschrijving